Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Calcium signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬1. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||
2 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Calcium signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬1. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||
3 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Bosentan Bosentan 💬cAMP signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬3. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||
4 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Bosentan Bosentan 💬cAMP signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬3. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||
5 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬cGMP-PKG signaling pathway
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬5. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||
6 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬cGMP-PKG signaling pathway
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬5. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||
7 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬cGMP-PKG signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬7. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||
8 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬cGMP-PKG signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬7. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||
9 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
PDE5 [1] PDE5 💬cGMP-PKG signaling pathway
|
Sildenafil citrate Sildenafil citrate 💬cGMP-PKG signaling pathway
| Sildenafil | 006 [14] 6 , 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬9. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||
10 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
PDE5 [1] PDE5 💬cGMP-PKG signaling pathway
|
Sildenafil Sildenafil 💬cGMP-PKG signaling pathway
| Sildenafil | 006 [14] 6 , 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬9. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||
11 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Hormone signaling
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬11. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||
12 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Hormone signaling
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬11. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||
13 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Hormone signaling
| Liothyronine | 013 [3] 13, 210, 212 💬13. Hormone signaling |
||||||||||||||||||||||||||||||||||||||
14 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine Liothyronine 💬Hormone signaling
| Liothyronine | 013 [3] 13, 210, 212 💬13. Hormone signaling |
||||||||||||||||||||||||||||||||||||||
15 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Bosentan Bosentan 💬Melanogenesis
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬15. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||
16 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Bosentan Bosentan 💬Melanogenesis
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬15. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||
17 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Neuroactive ligand signaling
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬17. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||
18 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Neuroactive ligand signaling
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬17. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||
19 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine Dexmedetomidine 💬Neuroactive ligand-receptor interaction
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬19. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||
20 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬
|
Dexmedetomidine hydrochloride Dexmedetomidine hydrochloride 💬Neuroactive ligand-receptor interaction
| Dexmedetomidine | 002 [15] 2 , 4 , 6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬19. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||
21 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Neuroactive ligand-receptor interaction
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬21. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||
22 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Neuroactive ligand-receptor interaction
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬21. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||
23 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Neuroactive ligand-receptor interaction
| Liothyronine | 013 [3] 13, 210, 212 💬23. Neuroactive ligand-receptor interaction |
||||||||||||||||||||||||||||||||||||||
24 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine Liothyronine 💬Neuroactive ligand-receptor interaction
| Liothyronine | 013 [3] 13, 210, 212 💬23. Neuroactive ligand-receptor interaction |
||||||||||||||||||||||||||||||||||||||
25 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Pathways in cancer
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬25. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||
26 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Pathways in cancer
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬25. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||
27 | Purine metabolism 💬 30 genes, 40 drugs (DrugBank) and 73 diseases |
PDE5 [1] PDE5 💬Purine metabolism
|
Sildenafil citrate Sildenafil citrate 💬Purine metabolism
| Sildenafil | 006 [14] 6 , 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬27. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||
28 | Purine metabolism 💬 30 genes, 40 drugs (DrugBank) and 73 diseases |
PDE5 [1] PDE5 💬Purine metabolism
|
Sildenafil Sildenafil 💬Purine metabolism
| Sildenafil | 006 [14] 6 , 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬27. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||
29 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬29. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||
30 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬29. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||
31 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Bosentan Bosentan 💬Renin secretion
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬31. Renin secretion
|
||||||||||||||||||||||||||||||||||||||
32 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Bosentan Bosentan 💬Renin secretion
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬31. Renin secretion
|
||||||||||||||||||||||||||||||||||||||
33 | Thyroid hormone signaling pathway 💬 25 genes, 45 drugs (DrugBank) and 73 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Thyroid hormone signaling pathway
| Liothyronine | 013 [3] 13, 210, 212 💬33. Thyroid hormone signaling pathway |
||||||||||||||||||||||||||||||||||||||
34 | Thyroid hormone signaling pathway 💬 25 genes, 45 drugs (DrugBank) and 73 diseases |
THRA [2] THRA, THRB 💬
|
Liothyronine Liothyronine 💬Thyroid hormone signaling pathway
| Liothyronine | 013 [3] 13, 210, 212 💬33. Thyroid hormone signaling pathway |
||||||||||||||||||||||||||||||||||||||
35 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Bosentan Bosentan 💬Vascular smooth muscle contraction
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬35. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||
36 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Bosentan Bosentan 💬Vascular smooth muscle contraction
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬35. Vascular smooth muscle contraction
|
Calcium signaling pathway
86 genes, 214 drugs (DrugBank) and 143 diseases
cAMP signaling pathway
66 genes, 189 drugs (DrugBank) and 130 diseases
cGMP-PKG signaling pathway
49 genes, 132 drugs (DrugBank) and 124 diseases
Hormone signaling
66 genes, 211 drugs (DrugBank) and 153 diseases
Melanogenesis
7 genes, 19 drugs (DrugBank) and 34 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 117 diseases
Neuroactive ligand-receptor interaction
158 genes, 364 drugs (DrugBank) and 173 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
Purine metabolism
30 genes, 40 drugs (DrugBank) and 73 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 51 diseases
Renin secretion
28 genes, 87 drugs (DrugBank) and 113 diseases
Thyroid hormone signaling pathway
25 genes, 45 drugs (DrugBank) and 73 diseases
Vascular smooth muscle contraction
32 genes, 92 drugs (DrugBank) and 71 diseases